|
⚲
|
| Keyboard |
| Castleman Peter M
✚
|
|
|---|---|
| CIK # | 0001239594 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001239594] | |
| 4 | [0001239594] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Caris Life Sciences Inc | |
| Castleman Peter M |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Caris Life Sciences Inc CAI
Common Stock
|
2026-02-26 | Grant | 5,509 | $20.06 | 110,511 |
|
Caris Life Sciences Inc CAI
Stock Option · derivative
|
2026-01-09 | Option exercise | 2,500 | $0.00 | |
|
Caris Life Sciences Inc CAI
Common Stock
|
2026-01-09 | Option exercise | 2,500 | $18.60 | 46,500 |
|
Caris Life Sciences Inc CAI
Series A Preferred Stock · derivative
|
2025-06-20 | Conversion | 40,983,607 | ||
|
Caris Life Sciences Inc CAI
Common Stock
|
2025-06-20 | Conversion | 10,245,906 | $0.00 | |
|
Caris Life Sciences Inc CAI
Stock Option · derivative
|
2025-02-27 | Grant | 2,500 | $0.00 | |
|
Caris Life Sciences Inc CAI
Common Stock
|
2025-02-27 | Grant | 16,129 | $0.00 |